Novi vs Shed: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Novi and Shed are tied at 7.8/10. Novi is more affordable at $133/mo vs $199/mo. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa. Choose Shed for users who want fast delivery and a streamlined compounded gl.
A side-by-side comparison of Novi and Shed covering pricing, scores, medication types, insurance, and more to help you decide.
Novi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit NoviShed
#17 of 46Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.
Visit Shed| Feature | Novi | Shed |
|---|---|---|
| Our Score | 7.8/10 | 7.8/10 |
| Starting Price | $133/mo | $199/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer | Users who want fast delivery and a streamlined compounded GLP-1 experience |
| Ranking | #14 | #17 |
Pros & Cons Compared
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Shed
Pros
- +Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
- +$149/mo is competitively priced for an all-inclusive compounded program with good support
- +Streamlined onboarding with no video call — approved and shipped faster than most competitors
- +Clean, modern UX with real-time shipping tracking and easy provider messaging
Cons
- −Compounded semaglutide and tirzepatide only — no brand-name options
- −Newer company (founded 2024) with limited track record and outcome data
- −No insurance billing and no FSA/HSA superbills currently available
- −Clinical support is responsive but less proactive than premium platforms
Our Verdict
Novi and Shed are closely matched with identical scores of 7.8/10. If budget is your priority, Novi starts at $133/mo compared to Shed's $199/mo. Shed offers both brand-name and compounded medications, giving you more flexibility. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.